de Toledo Piza, Cristina Frias Sartorelli
Aranda, Carolina Sanchez
Solé, Dirceu
Jolles, Stephen
Condino-Neto, Antonio http://orcid.org/0000-0002-1069-3117
Funding for this research was provided by:
Takeda Pharmaceuticals International (IISR-2020-103243)
Jeffrey Modell Foundation
CSL Behring
Article History
Received: 3 March 2023
Accepted: 9 June 2023
First Online: 28 July 2023
Change Date: 12 August 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10875-023-01568-7
Declarations
:
: The University of São Paulo and Federal University of São Paulo Ethics Committees approved the protocol (approval numbers 3.340.392 and 3.499.511, respectively) according to the Brazilian Ministry of Health and the Declaration of Helsinki rules and regulations.
: Written informed consent was obtained before the inclusion of participants and blood collection.
: All authors have reviewed the final manuscript and consented to publication.
: CFSTP, CSA, DS, and ACN declare no conflict of interests. SJ has received consulting fees, speaker fees, and research grants from CSL Behring, Takeda, and Octapharma. He is a member of the UCB Pharma Data Safety and Management Board.